Advancing the Management of Cholestatic Liver Disease: Optimizing Treatment Pathways and Emerging Therapies

In this activity, experts in adult and paediatric hepatology and gastroenterology explore practical strategies and evidence-based tools to diagnose and facilitate tailored treatment decision-making for primary biliary cholangitis (PBC) and progressive familial intrahepatic cholestasis (PFIC). 

Supported by: Ipsen Biopharmaceuticals, Inc. 

Organized by: PeerVoice

CME Provider: USF Health 

Link: https://cme.peervoice.com/140202451_1/140202451_1_p1/stage1reg?CountryID=US&ProjectNumber=140202451_1

Important Note: Continuing education credits for Satellite Symposia are offered by the sponsoring organizations. These sessions are not accredited by AASLD.

Science in the Park: How I Utilize Palliative Care

How do you study palliative care? Come discuss the science behind the recent Hepatology Communications article on the “Surprise Question,” a clinician-based prognostication tool initially developed to identify patients who may benefit from palliative care interventions with Dr. Nneka Ufere. Read the article here: https://journals.lww.com/hepcomm/fulltext/2025/08010/accuracy_of_the__surprise_question__in_predicting.7.aspx
 
12:45-12:55 PM- Presentation
12:55-1:15 PM- Audience Q&A and Discussion
 

Subscribe to